Feasibility study of 21-day-on/7-day-off temozolomide in children with brain tumors

MLA

Ridola, Vita, et al. Feasibility Study of 21-Day-on/7-Day-off Temozolomide in Children with Brain Tumors. 2011. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1104998457&authtype=sso&custid=ns315887.

APA

Ridola, V., Barone, G., Lazzareschi, I., Ruggiero, A., Rizzo, D., Riccardi, R., Lazzareschi, I. (ORCID:0000-0001-7221-2983), Ruggiero, A. (ORCID:0000-0002-6052-3511), Rizzo, D. (ORCID:0000-0003-1809-5901), & Riccardi, R. (ORCID:0000-0001-7515-6622). (2011). Feasibility study of 21-day-on/7-day-off temozolomide in children with brain tumors.

Chicago

Ridola, Vita, Giuseppe Barone, Ilaria Lazzareschi, Antonio Ruggiero, Daniela Rizzo, Riccardo Riccardi, Ilaria (ORCID:0000-0001-7221-2983) Lazzareschi, Antonio (ORCID:0000-0002-6052-3511) Ruggiero, Daniela (ORCID:0000-0003-1809-5901) Rizzo, and Riccardo (ORCID:0000-0001-7515-6622) Riccardi. 2011. “Feasibility Study of 21-Day-on/7-Day-off Temozolomide in Children with Brain Tumors.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1104998457&authtype=sso&custid=ns315887.